GlassScriptPhysician profile
Joshua D Patterson
NPI 1053643890
$507.27
in general payments reported to CMS, 2019-2025
14 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $316 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $82.51 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Phathom Pharmaceuticals, INC. | $51.03 | 2024 | Voquezna |
| Abbvie INC. | $48.32 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $45.68 | 2024-2025 | Breztri |
| Glaxosmithkline, LLC. | $38.58 | 2024 | Trelegy Ellipta, Shingrix |
| Dynavax Technologies Corporation | $38.56 | 2024-2025 | Heplisav-B |
| Abbott Laboratories | $36.37 | 2024-2025 | Freestyle Libre 3 |
| Corium, LLC | $34.38 | 2025 | Azstarys |
| Dexcom, INC. | $34.14 | 2024-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.99 | 2024-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $19.95 | 2024 | Trintellix |
| Exact Sciences Corporation | $18.39 | 2024 | Cologuard Collection Kit |
| Currax Pharmaceuticals LLC | $15.70 | 2025 | Contrave |
| Hikma Pharmaceuticals USA | $14.67 | 2024 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.